Form D · Pharmaceuticals
ZS Pharma, Inc.
Coppell, TX · CIK 0001459266
Offering snapshot reported Mar 11, 2014 · SEC filing
- Reported sold
- $25M Offering amount: $25M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2014 | Initial | $25,000,000 | No comparison | 12 | SEC filing |
| Oct 23, 2012 | Initial | $27,600,001 | No comparison | 6 | SEC filing |
| Jul 10, 2012 | Amendment | $5,305,000 | $1,000,000vs Dec 12, 2011 | 12 | SEC filing |
| Dec 12, 2011 | Amendment | $4,305,000 | $375,000vs Nov 22, 2011 | 12 | SEC filing |
| Nov 22, 2011 | Initial | $3,930,000 | No comparison | 12 | SEC filing |
| Dec 20, 2010 | Initial | $792,000 | No comparison | 11 | SEC filing |
| Dec 13, 2010 | Amendment | $1,195,972 | $913,647vs Mar 30, 2009 | 30 | SEC filing |
| Mar 30, 2009 | Initial | $282,325 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213340
Source: Form D, filed Mar 11, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Alexander | Director, Executive |
| Stephen R. Ash | Executive |
| Joy Barton | Executive |
| Nels P. Bergmark | Executive |
| Todd Creech | Executive |
| Miles B. Davis | Director |
| Alvaro F. Guillem | Director, Executive |
| Donald Jeffrey Keyser | Director, Executive |
| William Kushner | Executive |
| John Mc Kearn | Director |
| Guy Nohra | Director |
| Tim Opler | Director, Executive |
| Marc Ostro | Director |
| Henrik Sandvad Rasmussen | Executive |
| Henrick Sandvad Rasmussen | Executive |
| Cynthia Smith | Executive |
| Robert B. Truitt | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
508 Wrangler Drive Suite 100
Coppell, TX, 75019
Coppell, TX, 75019